REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 219 filers reported holding REATA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.91 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $490,604 | +98.6% | 5,396 | +119.5% | 0.00% | 0.0% |
| Q3 2021 | $247,000 | -22.6% | 2,458 | +9.1% | 0.00% | 0.0% |
| Q2 2021 | $319,000 | +20.8% | 2,252 | -15.1% | 0.00% | 0.0% |
| Q1 2021 | $264,000 | +18.4% | 2,651 | +47.2% | 0.00% | 0.0% |
| Q4 2020 | $223,000 | -34.2% | 1,801 | -17.2% | 0.00% | 0.0% |
| Q2 2020 | $339,000 | – | 2,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $94,902,000 | 15.92% |
| Opaleye Management Inc. | 407,002 | $13,333,000 | 4.14% |
| Ikarian Capital, LLC | 649,600 | $21,281,000 | 2.80% |
| AWH Capital, L.P. | 150,000 | $2,459,457 | 2.54% |
| Boxer Capital, LLC | 1,239,000 | $40,590,000 | 2.09% |
| EcoR1 Capital, LLC | 1,975,611 | $64,721,000 | 2.02% |
| Camber Capital Management LP | 1,500,000 | $49,140,000 | 1.78% |
| MPM BioImpact LLC | 180,000 | $5,897,000 | 1.58% |
| Sofinnova Investments, Inc. | 602,545 | $19,739,000 | 1.50% |
| KRS Capital Management, LLC | 28,141 | $921,000 | 1.00% |